Search results for: 'services ad predictive maintenance'

This analysis explores the transformation of healthcare from reactive disease treatment toward proactive, continuous, and personalized health management driven by AI, digital health, and predictive intelligence. Rising chronic disease burdens, aging populations, and escalating healthcare costs are accelerating demand for early detection, continuous...

Predictive genetic testing (PGT) comprises analysis of genes, the whole genome, or exomes to predict the risk of a wide range of disorders. It can have long-term implications in preventive healthcare practices, including delayed onset of disease, treatment management, pharmacogenomics, and general wellness. One outcome of the COVID-19 pandemic has ...

Frost & Sullivan expects the global MedTech managed vendor services market to witness significant changes over the next few years, driven by the increasing technology adoption by managed equipment services (MES), multi-vendor services (MVS), and professional service providers. They will do so due to the transformations in healthcare facilities, the...

21 Mar 2025  |  Global  |  Market Research

Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030

The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model

Infographics

×

As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...

23 Aug 2022  |  North America  |  Market Research

Global Bioanalytical Testing Services, 2021–2027

Acquisition of Disruptive Technologies will be the Key to Driving Growth

Infographics

×

Key Issues Addressed

As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug dev...

The objective of this study is to assess the market potential of current testing areas pertaining to the area of genetics such as diagnostic testing/screeening, relationship testing and predictive testing. Revenue forecast has been provided for 2010-2018 for each segment within the United Kingdom, Germany, France, Italy, Spain, Scandinavia and Bene...

The year 2023 will begin with three disruptive forces already playing out. The first is inflationary pressure on wages. The global labor market is expected to remain tight due to aging workforces and stringent immigration policies. The COVID-19 pandemic’s impact on labor force turnover rates will keep price inflation higher than pre-pandemic lev...

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...

As the number of aging, technologically obsolete imaging systems at medical facilities heightens the need for replacement to new imaging equipment with advanced technology, hospitals and imaging centers (especially in developing economies) seek Managed Equipment Services models that provide a viable long-term equipment procurement strategy. Managed...